💊
📋 Product Guide Updated July 2026 ⏱ 9 min read

FDA Registration for
Supplement Manufacturers — 2026 Guide

Supplements are legally food, not drugs — but the manufacturing standard is closer to pharmaceutical rigor than most food categories, and introducing a new ingredient means a formal 75-day safety notification most exporters have never heard of.

Quick answer: Yes — dietary supplement manufacturers need standard FDA Food Facility Registration and a U.S. Agent, the same as other food categories. What's different is the manufacturing standard: supplements follow a dedicated cGMP regulation (21 CFR Part 111), and any new dietary ingredient not used in the U.S. food supply before October 15, 1994 requires a 75-day premarket safety notification. Orionex provides Food Facility Registration and U.S. Agent services for supplement manufacturers starting at $300/year.

Food by Legal Category, Pharmaceutical-Adjacent in Practice

Under DSHEA (the Dietary Supplement Health and Education Act of 1994), supplements are legally classified as food, not drugs — they don't go through FDA premarket approval the way a new drug does. But that doesn't mean the manufacturing bar is low. Supplements have their own dedicated Current Good Manufacturing Practice regulation, distinct from and generally more detailed than standard food GMP, precisely because the products are concentrated, often potent, and consumed specifically for a health purpose.

$0
FDA Fee for Food Facility Registration
21 CFR 111
Dietary Supplement cGMP Regulation
75 Days
Premarket Notice Required for New Ingredients

Dietary Supplement cGMP — 21 CFR Part 111

This regulation governs manufacturing, packaging, labeling, and holding operations specifically for dietary supplements, and FDA inspects against it across several distinct facility roles — not just the manufacturer, but also companies that introduce their own brand of finished product into commerce without manufacturing it themselves, warehouse facilities storing supplements, and packaging/labeling-only operations. If your business touches a supplement product at any of these stages, cGMP obligations likely apply to you specifically, not just to whoever runs the production line.

⚠️

Private label brands take note: if you're the brand owner introducing a contract-manufactured supplement into commerce under your own label, you have cGMP-relevant obligations too — this isn't purely a "manufacturer's problem" you can fully delegate.

New Dietary Ingredient (NDI) Notification

If your supplement contains a dietary ingredient that was not present in the U.S. food supply, in an unaltered chemical form, before October 15, 1994, you likely need to submit a New Dietary Ingredient (NDI) notification — a premarket safety submission filed at least 75 days before the ingredient or supplement enters interstate commerce, under 21 CFR 190.6. The notification must include the safety basis for concluding the ingredient will reasonably be expected to be safe under its labeled conditions of use.

This catches many exporters off guard, particularly with novel botanicals, newer forms of established nutrients, or ingredients common in other markets but new to the U.S. — "it's sold safely elsewhere" is not the same as "it's cleared the U.S. NDI process."

💡

Current status, 2026: FDA has been working toward finalized NDI guidance, with a target of publishing the first section by late 2026, and has a draft policy for companies with past NDI compliance gaps to voluntarily correct them through a "Catch-up New Dietary Ingredient Submission" process. If your ingredient history has a gap, this evolving policy is worth tracking rather than assuming the issue has resolved itself.

No Mandatory Product Listing — Unlike Cosmetics

Here's a genuinely useful point of contrast if you've also read our cosmetic product listing guide: cosmetics under MoCRA now require mandatory FDA product listing for every product. Dietary supplements currently do not have an equivalent mandatory listing requirement. Legislative proposals to create one have been introduced in Congress, but as of 2026, none have been enacted. This means FDA's visibility into exactly what supplement products exist in the market remains more limited than its visibility into cosmetics — worth knowing, though it doesn't reduce your registration, cGMP, or NDI obligations.

Structure/Function Claims — A Notification Requirement, Not Just Word Choice

Unlike the cosmetic and OTC drug categories covered elsewhere in this series, where the cosmetic/drug line is purely about word choice, supplements making a structure/function claim (e.g., "supports immune health") must actually notify the FDA about that claim — not just choose careful wording, but file a formal notification. Disease claims (claiming to treat, cure, or prevent a specific disease) are not permitted for supplements at all and would reclassify the product as an unapproved drug. See our existing dietary supplement labeling guide for the full claims framework.

Serious Adverse Event Reporting

Under the Dietary Supplement and Nonprescription Drug Consumer Protection Act, manufacturers, packers, and distributors whose name appears on a supplement label must report serious adverse events to the FDA — a parallel obligation to the adverse event reporting seen in MoCRA cosmetics, though under separate statutory authority specific to supplements and OTC drugs.

FSVP for Supplement Importers

U.S. importers of dietary supplements must maintain a Foreign Supplier Verification Program (FSVP) for each foreign supplier — no supplement-specific exemption applies. See our FSVP service page for pricing and scope.

U.S. Agent Requirement for Supplement Facilities

Every foreign supplement manufacturing facility registering with the FDA must designate a U.S. Agent physically located in the United States, the same as other food facilities.

Orionex Regulatory Solutions is a trusted FDA U.S. Agent for dietary supplement manufacturers, physically based in Casper, Wyoming USA. Learn about our Food Facility Registration services →

Supplement Manufacturer Compliance Checklist

1

FDA Food Facility Registration

Register your facility and designate a U.S. Agent — the baseline requirement.

2

Confirm cGMP Compliance Under 21 CFR 111

Applies to manufacturers, brand owners, warehouses, and packaging/labeling operations alike.

3

Check Every Ingredient's Pre-1994 Status

File an NDI notification at least 75 days before market entry if any ingredient is new to the U.S. food supply.

4

Notify FDA of Structure/Function Claims

Not just careful wording — an actual filed notification, distinct from the cosmetic/drug claims approach.

5

FSVP Program

U.S. importers need a complete FSVP program per supplier.

6

Renew Every Two Years

Food Facility Registration renews biennially — next window: October 1 – December 31, 2026. See our renewal guide.

What Orionex Provides for Supplement Manufacturers

The FDA charges no government fee for Food Facility Registration. Orionex's fixed pricing:

💡

Note: Orionex handles your Food Facility Registration, U.S. Agent designation, and importer FSVP program. NDI notification preparation and cGMP consulting require a regulatory affairs specialist familiar with your specific ingredients and process — contact us if you'd like a referral.

Why Supplement Manufacturers Choose Orionex

💊 Trusted by Supplement Manufacturers

FDA Registration & U.S. Agent for Supplements — From $300/Year

Orionex handles FDA Food Facility Registration and U.S. Agent services for dietary supplement manufacturers, plus FSVP program development for U.S. importers sourcing from abroad.

Vitamin & mineral supplement manufacturers
Botanical & herbal supplement brands
Protein & sports nutrition companies
Probiotic supplement manufacturers
Private label supplement brands
U.S. importers needing supplement FSVP
View Services & Get Started →